Use of a Generative AI (Gen-AI) Chatbot for Anxiety and Depression Among Persons With Cannabis Use

Part of paid clinical trials in Lebanon, New Hampshire.

Sponsor
Trustees of Dartmouth College
Study ID
NCT06920238
Phase
PHASE1
Status
Recruiting
Apply to this trial

Conditions

  • Anxiety
  • Cannabis Use Disorder
  • Depression - Major Depressive Disorder
  • Depression, Anxiety

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Therabot-CALM — DEVICE
    Therabot is a generative-AI-driven mobile app designed to provide mental health treatment. The feasibility of Therabot-CALM, an adapted Therabot application, is being tested for the future use of treating co-occurring substance use disorders and anxiety and/or depression. The primary purpose of this study is application feasibility.

Study Details

The goal of this clinical trial is to learn if Therabot-CALM (Cannabis, Anxiety, Low Mood) has acceptability among users and could work to improve the symptoms of persons with cannabis use disorder and anxiety and/or depression. The main question it aims to answer is: What is the usability, feasibility, and acceptability of Therabot-CALM in persons with Cannabis Use Disorder and Anxiety and/or Depression? Participants will * Take a screening questionnaire * Participate in two virtual 1-hour interviews to provide feedback on app design and suggest features. * Engage with Therabot-CALM in a 4-week clinical trial and provide feedback on their app experience in a third virtual interview

Key Dates

Start date
Apr 13, 2025
Status verified
Sep 2025
Primary completion
Dec 31, 2025
Completion
Dec 31, 2025

Study Design

Enrollment
15 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY

Arms

  • Experimental: Therabot-CALM
    Participants will engage in three one-hour interviews and a 4-week clinical trial where they may interact with Therabot-CALM as much or as little as they want.

Primary Outcome Measure

Feasibility [ Time Frame: From enrollment to the end of the third interview at around 10 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
46 Centerra Parkway, Suite 300, Office #333SLebanonNew Hampshire03766
Nicholas C Jacobson, Ph.D.
[email protected]
8148630115

Find similar trials in Lebanon, NH

By research site
46 Centerra Parkway, Suite 300, Office #333S· Lebanon, NH

Related Studies